Mobile

Study to compare the mirabegron concentrations in blood after administration of mirabegron as tablet and oral suspension in healthy subjects and to evaluate the food effect

Mise à jour : Il y a 4 ans
Référence : EUCTR2014-001446-24

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To assess the bioavailability of 50 mg mirabegron oral suspension relative to that of the 50 mg mirabegron modified release tablet when dosed under fasted conditions.

Critère d'inclusion

  • No medical indication will be investigated as only healthy subjects will be included

Liens